Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sebaceous Cell Tumor of Eyelid 1Neoplasms 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Exome Sequencing × Clear all
NCT04471961 2025-09-30

ALADIN

University Hospital, Montpellier

Phase NA Active not recruiting
100 enrolled
Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT06080009 2024-02-23

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
20 enrolled

Sebaceous Cell Tumor of Eyelid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡